DarioHealth Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by DarioHealth Corp. on June 6, 2022, regarding an event that occurred on May 30, 2022. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market under the symbol "DRIO."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Departure of Director: The Company was informed of the death of Prof. Richard Stone, a member of the Board of Directors since 2014.
- Committee Roles: Prof. Stone served as a member of the Audit Committee and as the Chair of the Corporate Governance and Nominating Committee.
- Appointment of Director: To fill the resulting vacancies, the Board appointed Mr. Dennis Matheis, an existing independent director, to serve as a member of the Audit Committee and as a member and Chair of the Corporate Governance and Nominating Committee.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, or specific risk factors beyond the loss of a board member. No unusual items or contingencies were disclosed in this report.
Key Facts for Investor Verification
- Confirm the effective date of Mr. Dennis Matheis's new committee assignments.
- Verify if the Board intends to appoint a new director to fill the vacancy left by Prof. Stone or if the current board size will remain reduced.
- Review subsequent filings for any impact on the Company's audit processes or governance structure.